Mesalazine alveolitis in a patient with ulcerative colitis Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003
Prevalence of respiratory disorders in patients with ulcerative colitis Source: Eur Respir J 2007; 30: Suppl. 51, 567s Year: 2007
Respiratory manifestations in ulcerative colitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=168 Year: 2005
Expression of heat shock proteins in chronic obstructive pulmonary disease, vernal keratoconjunctivitis and ulcerative colitis Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Pulmonary involvement of inflammatory bowel disease in children and adult patients Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010
Cell profile and lymphocyte subsets from induced sputum (IS) in non atopic patients with ulcerative colitis (UC) Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
Pulmonary manifestations in Crohn's disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=151 Year: 2005
Functional and inflammatory bowel diseases in patients with COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Diffuse parenchymal lung inflammation response in patients with inflammatory bowel disease Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005
Prevalence of adenomatous colorectal polyp in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008
Role of bronchial and alveolar exhaled nitric oxide in patients with ulcerative colitis (UC) Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010
Effects of pantoperazole on pulmonary function tests of chronic obstructive pulmonary disease patients, with and without gastro esophageal reflux Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011
Pulmonary function in children with inflammatory bowel disease do not differ from healthy population Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011
Airway and lung involvement in inflammatory bowel disease Source: Eur Respir Monogr 2019; 86: 228-261 Year: 2019
Determination of levels of markers of systemic inflammation in patients with chronic bronchitis in combination with concomitant gastroesophageal reflux disease Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019
Microcarcinoids of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011